There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Yvonne Hunte |
| Institution: | Hoag Memorial Hospital Presbyterian |
| Department: | Neuroscience |
| Country: | |
| Proposed Analysis: | The Impact of Racial Disparities on Dementia Types in the Black Community By 2050, it is suspected that the White population will significantly decrease. Investigating the racial disparities in dementia will expand our knowledge base of risk for dementia types in the Black community. Findings can inform future research in preventative interventions to reduce the racial disparities in Alzheimer’s disease and dementia. To date, there is limited research exploring the diagnosis, treatment, and prevention of Alzheimer’s disease amongst minority people groups, particularly the Black community. Prior research indicates the apolipoprotein 4 allele (APOE-4) status is associated with a greater risk of developing Alzheimer’s disease in Black individuals when compared to non-Hispanic whites (Barnes & Bennett, 2014). As such, the current study will match Black and White individuals based on age, education, and APOE status to assess the impact of racial identity on cognitive impairment as measured by total CDRS and MoCA score. It is expected that Black individuals’ will be more cognitively impaired than their White counterparts. In controlling for APOE-4 status, age, and education amongst Black and White participants, the current study seeks to explore the impact of race on the severity of dementia. |
| Additional Investigators | |
| Investigator's Name: | Lauren Bennett |
| Proposed Analysis: | The Impact of Racial Disparities on Dementia Types in the Black Community By 2050, it is suspected that the White population will significantly decrease. Investigating the racial disparities in dementia will expand our knowledge base of risk for dementia types in the Black community. Findings can inform future research in preventative interventions to reduce the racial disparities in Alzheimer’s disease and dementia. To date, there is limited research exploring the diagnosis, treatment, and prevention of Alzheimer’s disease amongst minority people groups, particularly the Black community. Prior research indicates the apolipoprotein 4 allele (APOE-4) status is associated with a greater risk of developing Alzheimer’s disease in Black individuals when compared to non-Hispanic whites (Barnes & Bennett, 2014). As such, the current study will match Black and White individuals based on age, education, and APOE status to assess the impact of racial identity on cognitive impairment as measured by total CDRS and MoCA score. It is expected that Black individuals’ will be more cognitively impaired than their White counterparts. In controlling for APOE-4 status, age, and education amongst Black and White participants, the current study seeks to explore the impact of race on the severity of dementia. |
